Dr. Wolchok is Associate Attending Physician at Memorial Sloan-Kettering Cancer Center with expertise in the treatment of metastatic melanoma. He is also the co-director of the Swim Across America laboratory at MSKCC, one of the foremost immunotherapy and melanoma research groups in the country. His specific research interest is the preclinical and early clinical development of novel immunologic therapies. Most recently, Dr. Wolchok has initiated several clinical trials using plasmid DNA vaccines for patients with melanoma. He has been involved in the development of the DNA vaccine program at every level, from initial studies in mouse models through regulatory review and now as Principal Investigator of the clinical trials. Dr. Wolchok has authored numerous articles concerning DNA vaccines, cytokine biology and clinical care of melanoma and co-authored two chapters in the definitive textbook, Cutaneous Melanoma. Dr. Wolchok is also co-editor of the journal Cytotherapy. Most recently, Dr. Wolchok was appointed to be Associate Director of the Ludwig Center for Cancer Immunotherapy at MSKCC as well as Director of Immunotherapy Clinical Trials.